We're thrilled to welcome Seguros SURA Colombia to the SOPHiA GENETICS community as they adopt MSK-ACCESS® powered by SOPHiA DDM™ to advance their precision oncology research initiatives.
As one of Latin America's leading healthcare organizations, Seguros SURA Colombia is recognized for its commitment to driving innovation and research that strengthens the healthcare ecosystem. By implementing this cutting-edge liquid biopsy solution for research purposes, SURA is empowering its teams to generate insights that will help advance precision medicine initiatives in Colombia and across the region.
"We are excited to integrate MSK-ACCESS® powered by SOPHiA DDM™ into our Omics Sciences Center. This platform will enable us to deepen our understanding of cancer biology and contribute to the growth of precision medicine in Colombia." Said Carlos Andrés Agudelo, Manager of the Biosciences Center, Seguros SURA Colombia
At SOPHiA GENETICS, our mission is to democratize data-driven medicine worldwide by giving healthcare and research institutions access to powerful, AI-enabled analytics that transform complex data into meaningful insights. We're proud to partner with Seguros SURA Colombia as they take this important step toward advancing precision oncology research across the region.
Here's to expanding access to innovation and accelerating research for better outcomes.
Learn more about MSK-ACCESS® powered with SOPHiA DDM™: https://www.sophiagenetics.com/sophia-ddm-for-genomics/liquid-biopsy/msk-access/